Teen-brain denial in South Africa; NZ's untold detransition stories; anti-Cass bias in Australia; German docs reject hate smears; judicial activism thwarted in Brazil; pressure for answers in Norway
It seems to me to be obvious that experimenting on children with healthcare that obviously isn’t healthcare but has very sad outcomes is just plain wrong. But then the same people did the same thing with dangerous unproven covid injections. My motto is don’t trust and ask lots of questions.
The ‘identity breakdown’ of transgender adults according to the ‘Williams Institute’ study in the US indicates is that there exists an approximate three-way near-equal split between ‘women’, ‘men’ and ‘binary’. Perhaps the situation is similar in Australia?
This equation is important as there are significantly elevated risk realities associating with the transgender women cohort for two reasons:
A high prevalence of sexually transmitted conditions and criminal activity:
1. Numerous studies confirm that TG women have high prevalence of HIV/AIDS. I cannot find current figures for HIV prevalence in this cohort in Australia however a study in 2018 indicated that the prevalence of HIV among the TG women cohort was 49 times that of the general population. In the United States HIV prevalence is highest among transgender women with recent estimates ranging from 14.1% to 18.8%.
2. I found it difficult to find recent figures for bacterial sexually transmitted diseases in this cohort however a study from 2017 indicated the following prevalences: Chlamydia 10%, Gonorrhoea 8% and Syphilis 3.1%
Criminal Activity:
Transgender women were over six times more likely to be convicted of an offence than female comparators and 18 times more likely to be convicted of a violent offence. Finally, as might be expected, studies imply that gender women exhibit a male-type patterns of criminality.
Dr Anastasia Tomson said: “In testing new agents or existing drugs that have never been applied to TB before, we don’t compare them to a placebo or to non-intervention, because we know it’s unethical. We know that we can’t withhold treatment in the name of building a body of evidence.”
This shows the extreme ignorance of this TransGender Doctor activist.
Of course we would not test a new TB treatment that had not been tested in TB before, in a randomised controlled trial. The new treatment would need to have shown efficacy in Phase 2 (uncontrolled) trials presumably after failure of the known effective treatment prior to progressing to a controlled trial.
This is completely different to medical affirmation, where there is no evidence of efficacy and proven evidence of harm.
You would expect overwhelming efficacy evidence to justify
treatment that causes irreversible body changes plus other risks such as osteoporosis.
But the protagonists can’t even agree on what the efficacy end point is. They have now virtually conceded that it doesn’t improve mental health, so now they say that as long as the patients achieve their wish, that is proof of efficacy.
If this is medicine it is certainly not the medicine I was taught.
It seems to me to be obvious that experimenting on children with healthcare that obviously isn’t healthcare but has very sad outcomes is just plain wrong. But then the same people did the same thing with dangerous unproven covid injections. My motto is don’t trust and ask lots of questions.
BUYER BEWARE
The ‘identity breakdown’ of transgender adults according to the ‘Williams Institute’ study in the US indicates is that there exists an approximate three-way near-equal split between ‘women’, ‘men’ and ‘binary’. Perhaps the situation is similar in Australia?
This equation is important as there are significantly elevated risk realities associating with the transgender women cohort for two reasons:
A high prevalence of sexually transmitted conditions and criminal activity:
1. Numerous studies confirm that TG women have high prevalence of HIV/AIDS. I cannot find current figures for HIV prevalence in this cohort in Australia however a study in 2018 indicated that the prevalence of HIV among the TG women cohort was 49 times that of the general population. In the United States HIV prevalence is highest among transgender women with recent estimates ranging from 14.1% to 18.8%.
2. I found it difficult to find recent figures for bacterial sexually transmitted diseases in this cohort however a study from 2017 indicated the following prevalences: Chlamydia 10%, Gonorrhoea 8% and Syphilis 3.1%
Criminal Activity:
Transgender women were over six times more likely to be convicted of an offence than female comparators and 18 times more likely to be convicted of a violent offence. Finally, as might be expected, studies imply that gender women exhibit a male-type patterns of criminality.
Dr Anastasia Tomson said: “In testing new agents or existing drugs that have never been applied to TB before, we don’t compare them to a placebo or to non-intervention, because we know it’s unethical. We know that we can’t withhold treatment in the name of building a body of evidence.”
This shows the extreme ignorance of this TransGender Doctor activist.
Of course we would not test a new TB treatment that had not been tested in TB before, in a randomised controlled trial. The new treatment would need to have shown efficacy in Phase 2 (uncontrolled) trials presumably after failure of the known effective treatment prior to progressing to a controlled trial.
This is completely different to medical affirmation, where there is no evidence of efficacy and proven evidence of harm.
You would expect overwhelming efficacy evidence to justify
treatment that causes irreversible body changes plus other risks such as osteoporosis.
But the protagonists can’t even agree on what the efficacy end point is. They have now virtually conceded that it doesn’t improve mental health, so now they say that as long as the patients achieve their wish, that is proof of efficacy.
If this is medicine it is certainly not the medicine I was taught.
Perhaps there is a level of desperation in South Africa in the face of multiple chronic illnesses?